Chris Francis sold $6.4M of WVE
See Remarks at Wave Life Sciences Ltd.. 441,031 shares at an average of $14.57, traded Dec 8, 2025, filed Dec 10, 2025.
Score components
- +15RoleOfficer
- +25Trade size$6.4M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster8 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-314737, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +28,125 | $3.14 | $88k | 53,125 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -28,125 | $14.50 | $408k | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +107,400 | $3.87 | $416k | 132,400 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -107,400 | $14.56 | $1.6M | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +45,882 | $4.75 | $218k | 70,882 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -45,882 | $14.50 | $665k | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +9,375 | $3.14 | $29k | 34,375 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -9,375 | $15.00 | $141k | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +37,500 | $3.14 | $118k | 62,500 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -37,500 | $14.08 | $528k | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +17,900 | $3.87 | $69k | 42,900 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -17,900 | $15.00 | $269k | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +122,349 | $4.75 | $581k | 147,349 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -122,349 | $14.20 | $1.7M | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +50,000 | $10.48 | $524k | 75,000 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -50,000 | $16.00 | $800k | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Ordinary Shares10b5-1 | +22,500 | $2.83 | $64k | 47,500 | Dec 10, 2025 |
| Dec 8, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -22,500 | $14.08 | $317k | 25,000 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -75,000 | $0.00 | $0 | 9,375 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -125,300 | $0.00 | $0 | 161,100 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -168,231 | $0.00 | $0 | 76,469 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 8, 2025 | MOption exercise Share Option (right to buy)derivative10b5-1 | -22,500 | $0.00 | $0 | 0 | Dec 10, 2025 |
Related signals
Other insiders at Wave Life Sciences Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $500k 33,194 shares | -42% | |
| 44Moderate | Wave Life Sciences Ltd. | Paul Bolno President and CEO | $141k 10,480 shares | -4% | |
| 28Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $25k 1,883 shares | -3% | |
| 1Weak | Wave Life Sciences Ltd. | Chris Francis See Remarks | $150k 9,375 shares | -27% | |
| 39Weak | WVEbuy Wave Life Sciences Ltd. | GSK plc owner | $28M 1,470,000 shares | +9% | |
| 32Weak | Wave Life Sciences Ltd. | Mark Corrigan director | $217k 16,115 shares | -36% | |
| 40Moderate | Wave Life Sciences Ltd. | Christian O Henry director | $1.4M 93,445 shares | -488% | |
| 47Moderate | Wave Life Sciences Ltd. | Kyle Moran Chief Financial Officer | $4.1M 260,036 shares | -174% | |
| 35Weak | Wave Life Sciences Ltd. | Adrian Rawcliffe director | $630k 42,000 shares | -77% | |
| 40Moderate | Wave Life Sciences Ltd. | Aik Na Tan director | $1.8M 134,218 shares | -332% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.